Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Lagergård T[au]:

Search results

Items: 1 to 50 of 131

1.

On the evolution of the sexually transmitted bacteria Haemophilus ducreyi and Klebsiella granulomatis.

Lagergård T, Bölin I, Lindholm L.

Ann N Y Acad Sci. 2011 Aug;1230:E1-E10. doi: 10.1111/j.1749-6632.2011.06193.x. Review.

PMID:
22239475
2.

The evolution of infectious agents in relation to sex in animals and humans: brief discussions of some individual organisms.

Reed DL, Currier RW, Walton SF, Conrad M, Sullivan SA, Carlton JM, Read TD, Severini A, Tyler S, Eberle R, Johnson WE, Silvestri G, Clarke IN, Lagergård T, Lukehart SA, Unemo M, Shafer WM, Beasley RP, Bergström T, Norberg P, Davison AJ, Sharp PM, Hahn BH, Blomberg J.

Ann N Y Acad Sci. 2011 Aug;1230:74-107. doi: 10.1111/j.1749-6632.2011.06133.x. Review.

3.

Oligosaccharide conjugates of Bordetella pertussis and bronchiseptica induce bactericidal antibodies, an addition to pertussis vaccine.

Kubler-Kielb J, Vinogradov E, Lagergård T, Ginzberg A, King JD, Preston A, Maskell DJ, Pozsgay V, Keith JM, Robbins JB, Schneerson R.

Proc Natl Acad Sci U S A. 2011 Mar 8;108(10):4087-92. doi: 10.1073/pnas.1100782108. Epub 2011 Feb 22.

4.

Detoxified Haemophilus ducreyi cytolethal distending toxin and induction of toxin specific antibodies in the genital tract.

Lundqvist A, Fernandez-Rodrigues J, Ahlman K, Lagergård T.

Vaccine. 2010 Aug 16;28(36):5768-73. doi: 10.1016/j.vaccine.2010.06.032. Epub 2010 Jul 4.

PMID:
20609397
5.

Distribution of Chlamydia trachomatis ompA genovars and the new variant of C. trachomatis in the Göteborg area, Sweden.

Lagergård T, Hadad R, Tunbäck P, Lindholm L, Löwhagen GB, Unemo M.

Eur J Clin Microbiol Infect Dis. 2010 May;29(5):609-11. doi: 10.1007/s10096-010-0887-1. Epub 2010 Mar 1.

PMID:
20195670
6.

Toxic activity of the CdtB component of Haemophilus ducreyi cytolethal distending toxin expressed from an adenovirus 5 vector.

Wising C, Magnusson M, Ahlman K, Lindholm L, Lagergård T.

APMIS. 2010 Feb;118(2):143-9. doi: 10.1111/j.1600-0463.2009.02573.x.

PMID:
20132178
7.

Immunogenic and adjuvant properties of Haemophilus ducreyi lipooligosaccharides.

Lundqvist A, Kubler-Kielb J, Teneberg S, Ahlman K, Lagergård T.

Microbes Infect. 2009 Mar;11(3):352-60. doi: 10.1016/j.micinf.2008.12.014. Epub 2009 Jan 14.

PMID:
19397884
8.

Cytolethal distending toxin upregulates RANKL expression in Jurkat T-cells.

Belibasakis GN, Brage M, Lagergård T, Johansson A.

APMIS. 2008 Jun;116(6):499-506.

PMID:
18754324
9.

Seroprevalences of herpes simplex virus type 2, five oncogenic human papillomaviruses, and Chlamydia trachomatis in Katowice, Poland.

Görander S, Lagergård T, Romanik M, Viscidi RP, Martirosian G, Liljeqvist JA.

Clin Vaccine Immunol. 2008 Apr;15(4):675-80. doi: 10.1128/CVI.00260-07. Epub 2008 Feb 20.

10.

[Streptococcus group B--association with Aerobic vaginitis and ability to human cell lines activation].

Romanik M, Kafel J, Lagergård T, Martirosian G.

Med Dosw Mikrobiol. 2007;59(2):85-91. Polish.

PMID:
17929406
11.

Formaldehyde treatment increases the immunogenicity and decreases the toxicity of Haemophilus ducreyi cytolethal distending toxin.

Lagergård T, Lundqvist A, Wising C, Gabrielsson V, Ahlman K.

Vaccine. 2007 May 4;25(18):3606-14. Epub 2007 Jan 23.

PMID:
17289219
12.

Binding of Haemophilus ducreyi to carbohydrate receptors is mediated by the 58.5-kDa GroEL heat shock protein.

Pantzar M, Teneberg S, Lagergård T.

Microbes Infect. 2006 Aug;8(9-10):2452-8. Epub 2006 Jul 7.

PMID:
16880000
13.

Prevalence of serum antibodies to human papilloma virus in patients with genital ulcer disease in an urban population of Tanzania.

Mbwana J, Viscidi R, Lyamuya E, Mhalu F, Chalamilla G, Liljeqvist JA, Lagergård T.

Sex Transm Infect. 2007 Feb;83(1):64-5. Epub 2006 Jun 28.

14.

Mature glycoprotein g presents high performance in diagnosing herpes simplex virus type 2 infection in sera of different tanzanian cohorts.

Görander S, Mbwana J, Lyamuya E, Lagergård T, Liljeqvist JA.

Clin Vaccine Immunol. 2006 Jun;13(6):633-9.

15.

Molecular characterization of Haemophilus ducreyi isolates from different geographical locations.

Mbwana J, Bölin I, Lyamuya E, Mhalu F, Lagergård T.

J Clin Microbiol. 2006 Jan;44(1):132-7.

16.

Diphtheria, tetanus and pertussis antibodies in 10-year-old children before and after a booster dose of three toxoids: implications for the timing of a booster dose.

Trollfors B, Knutsson N, Taranger J, Mark A, Bergfors E, Sundh V, Lagergård T.

Eur J Pediatr. 2006 Jan;165(1):14-8. Epub 2005 Oct 26.

PMID:
16249929
17.

Multilocus sequence typing of Swedish invasive group B streptococcus isolates indicates a neonatally associated genetic lineage and capsule switching.

Luan SL, Granlund M, Sellin M, Lagergård T, Spratt BG, Norgren M.

J Clin Microbiol. 2005 Aug;43(8):3727-33.

18.
19.

The cytolethal distending toxin of Haemophilus ducreyi aggravates dermal lesions in a rabbit model of chancroid.

Wising C, Mölne L, Jonsson IM, Ahlman K, Lagergård T.

Microbes Infect. 2005 May;7(5-6):867-74. Epub 2005 Apr 20.

PMID:
15876546
20.

Cytokine responses of human gingival fibroblasts to Actinobacillus actinomycetemcomitans cytolethal distending toxin.

Belibasakis GN, Johansson A, Wang Y, Chen C, Lagergård T, Kalfas S, Lerner UH.

Cytokine. 2005 Apr 21;30(2):56-63.

PMID:
15804596
21.

Induction of apoptosis/necrosis in various human cell lineages by Haemophilus ducreyi cytolethal distending toxin.

Wising C, Azem J, Zetterberg M, Svensson LA, Ahlman K, Lagergård T.

Toxicon. 2005 May;45(6):767-76.

PMID:
15804526
22.

Reduced immunogenicity of diphtheria and tetanus toxoids when combined with pertussis toxoid.

Trollfors B, Taranger J, Lagergård T, Sundh V.

Pediatr Infect Dis J. 2005 Jan;24(1):85-6.

PMID:
15665717
23.

Interactions of Haemophilus ducreyi and purified cytolethal distending toxin with human monocyte-derived dendritic cells, macrophages and CD4+ T cells.

Xu T, Lundqvist A, Ahmed HJ, Eriksson K, Yang Y, Lagergård T.

Microbes Infect. 2004 Nov;6(13):1171-81.

PMID:
15488736
24.

Specificity of antibodies directed against the cytolethal distending toxin of Haemophilus ducreyi in patients with chancroid.

Mbwana J, Ahmed HJ, Ahlman K, Sundaeus V, Dahlén G, Lyamuya E, Lagergård T.

Microb Pathog. 2003 Sep;35(3):133-7.

PMID:
12927521
25.

Determination of pertactin IgG antibodies for the diagnosis of pertussis.

Trollfors B, Lagergård T, Gunnarsson E, Taranger J.

Clin Microbiol Infect. 2003 Jul;9(7):585-9.

26.

Etiology of genital ulcer disease and association with human immunodeficiency virus infection in two tanzanian cities.

Ahmed HJ, Mbwana J, Gunnarsson E, Ahlman K, Guerino C, Svensson LA, Mhalu F, Lagergard T.

Sex Transm Dis. 2003 Feb;30(2):114-9.

PMID:
12567167
27.

Toxicity and immunogenicity of purified Haemophilus ducreyi cytolethal distending toxin in a rabbit model.

Wising C, Svensson LA, Ahmed HJ, Sundaeus V, Ahlman K, Jonsson IM, Mölne L, Lagergård T.

Microb Pathog. 2002 Aug;33(2):49-62.

PMID:
12202104
28.

The cytolethal distending toxin of Haemophilus ducreyi inhibits endothelial cell proliferation.

Svensson LA, Henning P, Lagergård T.

Infect Immun. 2002 May;70(5):2665-9.

29.

In vitro and in vivo interactions of Haemophilus ducreyi with host phagocytes.

Ahmed HJ, Johansson C, Svensson LA, Ahlman K, Verdrengh M, Lagergård T.

Infect Immun. 2002 Feb;70(2):899-908.

30.

Immunologic and epidemiologic experience of vaccination with a monocomponent pertussis toxoid vaccine.

Taranger J, Trollfors B, Bergfors E, Knutsson N, Lagergård T, Schneerson R, Robbins JB.

Pediatrics. 2001 Dec;108(6):E115. Review.

PMID:
11731642
31.

Prevalence of cdtABC genes encoding cytolethal distending toxin among Haemophilus ducreyi and Actinobacillus actinomycetemcomitans strains.

Ahmed HJ, Svensson LA, Cope LD, Latimer JL, Hansen EJ, Ahlman K, Bayat-Turk J, Klamer D, Lagergård T.

J Med Microbiol. 2001 Oct;50(10):860-4.

PMID:
11599734
32.

Mass vaccination of children with pertussis toxoid--decreased incidence in both vaccinated and nonvaccinated persons.

Taranger J, Trollfors B, Bergfors E, Knutsson N, Sundh V, Lagergård T, Lind-Brandberg L, Zackrisson G, White J, Cicirello H, Fusco J, Robbins JB.

Clin Infect Dis. 2001 Oct 1;33(7):1004-10. Epub 2001 Aug 22.

PMID:
11528572
33.

Serum immunoglobulin G antibody responses to Bordetella pertussis lipooligosaccharide and B. parapertussis lipopolysaccharide in children with pertussis and parapertussis.

Trollfors B, Lagergård T, Taranger J, Bergfors E, Schneerson R, Robbins JB.

Clin Diagn Lab Immunol. 2001 Sep;8(5):1015-7.

34.

Immunogenicity and reactogenicity of diphtheria, tetanus and pertussis toxoids combined with inactivated polio vaccine, when administered concomitantly with or as a diluent for a Hib conjugate vaccine.

Knutsson N, Trollfors B, Taranger J, Bergfors E, Sundh V, Lagergård T, Ostergaard E, Cicirello H, Käyhty H.

Vaccine. 2001 Aug 14;19(31):4396-403.

PMID:
11483264
35.

The role of different protein components from the Haemophilus ducreyi cytolethal distending toxin in the generation of cell toxicity.

Frisk A, Lebens M, Johansson C, Ahmed H, Svensson L, Ahlman K, Lagergård T.

Microb Pathog. 2001 Jun;30(6):313-24.

PMID:
11399138
36.
37.

The impact of Haemophilus ducreyi cytolethal distending toxin on cells involved in immune response.

Svensson LA, Tarkowski A, Thelestam M, Lagergård T.

Microb Pathog. 2001 Mar;30(3):157-66.

PMID:
11273741
38.

Serotypes and clinical manifestations of group B streptococcal infections in western Sweden.

Berg S, Trollfors B, Lagergård T, Zackrisson G, Claesson BA.

Clin Microbiol Infect. 2000 Jan;6(1):9-13.

39.

Group B Streptococcus capsular polysaccharide-cholera toxin B subunit conjugate vaccines prepared by different methods for intranasal immunization.

Shen X, Lagergård T, Yang Y, Lindblad M, Fredriksson M, Holmgren J.

Infect Immun. 2001 Jan;69(1):297-306.

40.
41.

Cellular internalization of cytolethal distending toxin from Haemophilus ducreyi.

Cortes-Bratti X, Chaves-Olarte E, Lagergård T, Thelestam M.

Infect Immun. 2000 Dec;68(12):6903-11.

42.

The Haemophilus ducreyi cytolethal distending toxin induces cell cycle arrest and apoptosis via the DNA damage checkpoint pathways.

Cortes-Bratti X, Karlsson C, Lagergård T, Thelestam M, Frisan T.

J Biol Chem. 2001 Feb 16;276(7):5296-302. Epub 2000 Nov 13.

43.
44.

Correlation between pertussis toxin IgG antibodies in postvaccination sera and subsequent protection against pertussis.

Taranger J, Trollfors B, Lagergård T, Sundh V, Bryla DA, Schneerson R, Robbins JB.

J Infect Dis. 2000 Mar;181(3):1010-3.

PMID:
10720524
45.

Protection against pertussis with a monocomponent pertussis toxoid vaccine.

Taranger J, Trollfors B, Lagergârd T, Robbins JB.

Biologicals. 1999 Jun;27(2):89. Review. No abstract available.

PMID:
10600190
46.

Vaccination of infants with a four-dose and a three-dose vaccination schedule.

Taranger J, Trollfors B, Knutsson N, Sundh V, Lagergård T, Ostergaard E.

Vaccine. 1999 Dec 10;18(9-10):884-91.

PMID:
10580202
47.

Parapertussis and pertussis: differences and similarities in incidence, clinical course, and antibody responses.

Bergfors E, Trollfors B, Taranger J, Lagergård T, Sundh V, Zackrisson G.

Int J Infect Dis. 1999 Spring;3(3):140-6.

48.

Characterization of a Haemophilus ducreyi mutant deficient in expression of cytolethal distending toxin.

Stevens MK, Latimer JL, Lumbley SR, Ward CK, Cope LD, Lagergard T, Hansen EJ.

Infect Immun. 1999 Aug;67(8):3900-8.

49.

Serum IgG antibody responses to pertussis toxin and filamentous hemagglutinin in nonvaccinated and vaccinated children and adults with pertussis.

Trollfors B, Taranger J, Lagergård T, Sundh V, Bryla DA, Schneerson R, Robbins JB.

Clin Infect Dis. 1999 Mar;28(3):552-9.

PMID:
10194077
50.

Immunity to pertussis. Not all virulence factors are protective antigens.

Robbins JB, Schneerson R, Bryla DA, Trollfors B, Taranger J, Lagergård T.

Adv Exp Med Biol. 1998;452:207-18. Review.

PMID:
9889975

Supplemental Content

Loading ...
Support Center